For: | Shen H, Yuan Y, Hu HG, Zhong X, Ye XX, Li MD, Fang WJ, Zheng S. Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients. World J Gastroenterol 2011; 17(6): 809-816 [PMID: 21390154 DOI: 10.3748/wjg.v17.i6.809] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i6/809.htm |
Number | Citing Articles |
1 |
Jing Chen, Fang Guo, Xin Shi, Lihua Zhang, Aifeng Zhang, Hui Jin, Youji He. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-802
|
2 |
Jen‐Fan Hang, Anna Fen‐Yau Li, Shih‐Ching Chang, Wen‐Yih Liang. Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test. Histopathology 2016; 69(1): 54 doi: 10.1111/his.12903
|
3 |
Youssef Mahdi, Mouna Khmou, Amine Souadka, Hajar El Agouri, Soumaya Ech-charif, Chaimaa Mounjid, Basma El Khannoussi. Correlation between KRAS and NRAS mutational status and clinicopathological features in 414 cases of metastatic colorectal cancer in Morocco: the largest North African case series. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02694-7
|
4 |
Yan-Zhi Chen, Dan Liu, Yu-Xia Zhao, He-Tong Wang, Ya Gao, Ying Chen. Aberrant promoter methylation of the SFRP1 gene may contribute to colorectal carcinogenesis: a meta-analysis. Tumor Biology 2014; 35(9): 9201 doi: 10.1007/s13277-014-2180-x
|
5 |
Ju-Xiang Ye, Yan Liu, Yun Qin, Hao-Hao Zhong, Wei-Ning Yi, Xue-Ying Shi. <italic>KRAS</italic> and <italic>BRAF</italic> gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. World Journal of Gastroenterology 2015; 21(5): 1595-1605 doi: 10.3748/wjg.v21.i5.1595
|
6 |
Min S. Kwak, Jae M. Cha, Young H. Cho, Sang H. Kim, Jin Y. Yoon, Jung W. Jeon, Hyun P. Shin, Kwang R. Joo, Joung I. Lee. Clinical Predictors for KRAS Codon 13 Mutations in Patients With Colorectal Cancer. Journal of Clinical Gastroenterology 2018; 52(5): 431 doi: 10.1097/MCG.0000000000000809
|
7 |
S.-H. Lee, B.-K. Ahn, S.-U. Baek, H.-K. Chang. BRAF mutation in multiple primary cancer with colorectal cancer and stomach cancer. Gastroenterology Report 2013; 1(1): 70 doi: 10.1093/gastro/got004
|
8 |
|
9 |
Mehrdad Payandeh, Babak Shazad, Masoud Sadeghi, Maryam Shahbazi. Correlation between RAS Test Results and Prognosis of Metastatic Colorectal Cancer Patients: a Report from Western Iran. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 1729 doi: 10.7314/APJCP.2016.17.4.1729
|
10 |
Mabel Elena Bohórquez L, Ángel Alexandro Criollo R, Luis Carvajal Carmona, María Magdalena Echeverry de Polanco. Cáncer de colon en Colombia, fenotipo molecular: tamizaje para síndromes con agregación familiar. Revista de la Asociación Colombiana de Ciencias Biológicas 2019; : 87 doi: 10.47499/revistaaccb.v1i31.185
|
11 |
Nasser Mulla, Abdulraheem Alshareef, Abdul Rahman Syed, Majid Al-Jahel. Clinico-Pathological Study of K-ras Mutations in Colorectal Tumors: A Single-Center Retrospective Study of 51 Patients in Madinah, Saudi Arabia. Cureus 2020; doi: 10.7759/cureus.9978
|
12 |
Qiwei Yang, Sibo Huo, Yujie Sui, Zhenwu Du, Haiyue Zhao, Yu Liu, Wei Li, Xin Wan, Tongjun Liu, Guizhen Zhang. Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00487
|
13 |
Identification of KRAS gene codon 12 polymorphism in colorectal cancer patients at Mohammad Hoesin General Hospital Palembang. Journal of Physics: Conference Series 2019; 1246(1): 012051 doi: 10.1088/1742-6596/1246/1/012051
|
14 |
B.N. Murtaza, A. Bibi, M.U. Rashid, Y.I. Khan, M.S. Chaudri, A.R. Shakoori. Spectrum of K ras mutations in Pakistani colorectal cancer patients. Brazilian Journal of Medical and Biological Research 2013; 47(1): 35 doi: 10.1590/1414-431X20133046
|
15 |
Cristina Santos, Eduardo Vilar, Gabriel Capella, Ramon Salazar. Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer. Colorectal Cancer 2013; 2(3): 243 doi: 10.2217/crc.13.24
|
16 |
Xiangyan Zhang, Wenwen Ran, Jie Wu, Hong Li, Huamin Liu, Lili Wang, Yujing Xiao, Xiaonan Wang, Yujun Li, Xiaoming Xing. Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China. PeerJ 2018; 6: e4341 doi: 10.7717/peerj.4341
|
17 |
Joel Petit, Georgia Carroll, Jie Zhao, Peter Pockney, Rodney J. Scott. The Prognostic Utility of KRAS Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients. Gastroenterology Insights 2024; 15(1): 107 doi: 10.3390/gastroent15010008
|
18 |
Yi-Xin Hao, Yong-Mei Li, Ming Ye, Yan-Yan Guo, Qiu-Wen Li, Xiu-Mei Peng, Qi Wang, Shu-Fang Zhang, Hui-Xia Zhao, He Zhang, Guang-Hui Li, Jian-Hua Zhu, Wen-Hua Xiao. KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population. Oncology Letters 2017; 13(5): 3608 doi: 10.3892/ol.2017.5889
|
19 |
Mahmood Moosazadeh, Azita sadough, Mahdi Afshari, Saeed barzegari, Ghasem Janbabaee, Reza Tabrizi, Maryam Akbari, Reza Alizadeh‐Navaei, Akbar Hedayatizadeh‐Omran, Fereshteh Rostami-Maskopaee. Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta‐analysis. European Journal of Cancer Care 2019; 28(6) doi: 10.1111/ecc.13160
|
20 |
Yu Imamura, Paul Lochhead, Mai Yamauchi, Aya Kuchiba, Zhi Rong Qian, Xiaoyun Liao, Reiko Nishihara, Seungyoun Jung, Kana Wu, Katsuhiko Nosho, Yaoyu E Wang, Shouyong Peng, Adam J Bass, Kevin M Haigis, Jeffrey A Meyerhardt, Andrew T Chan, Charles S Fuchs, Shuji Ogino. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-135
|
21 |
Xiangyan Zhang, Jie Wu, Lili Wang, Han Zhao, Hong Li, Yuhe Duan, Yujun Li, Ping Xu, Wenwen Ran, Xiaoming Xing. HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China. PeerJ 2020; 8: e8602 doi: 10.7717/peerj.8602
|
22 |
Soukaina Benmokhtar, Abdelilah Laraqui, Farida Hilali, Tahar Bajjou, Sara El Zaitouni, Meryem Jafari, Walid Baba, Hicham Elannaz, Idriss Amine Lahlou, Chahdi Hafsa, Mohamed Oukabli, Tarik Mahfoud, Rachid Tanz, Mohamed Ichou, Khaled Ennibi, Nadia Dakka, Yassine Sekhsokh. RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review. Clinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241255651
|
23 |
JiaoJiao Ren, GuangXiao Li, Jie Ge, Xia Li, YaShuang Zhao. Is K-ras Gene Mutation a Prognostic Factor for Colorectal Cancer. Diseases of the Colon & Rectum 2012; 55(8): 913 doi: 10.1097/DCR.0b013e318251d8d9
|
24 |
Renato Morato ZANATTO, Gianni SANTOS, Júnea Caris OLIVEIRA, Eduardo Marcucci PRACUCHO, Adauto José Ferreira NUNES, Gaspar Jesus LOPES-FILHO, Sarhan Sydney SAAD. IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2020; 33(3) doi: 10.1590/0102-672020200003e1524
|
25 |
Z Li, Y Chen, D Wang, G Wang, L He, J Suo. Detection of KRAS Mutations and Their Associations with Clinicopathological Features and Survival in Chinese Colorectal Cancer Patients. Journal of International Medical Research 2012; 40(4): 1589 doi: 10.1177/147323001204000439
|
26 |
Chen Mao, Junhua Zhou, Zuyao Yang, Yafang Huang, Xinyin Wu, Hong Shen, Jinling Tang, Qing Chen, Chad Creighton. KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer. PLoS ONE 2012; 7(5): e36653 doi: 10.1371/journal.pone.0036653
|
27 |
Ya-Sian Chang, Shun-Jen Chang, Kun-Tu Yeh, Tsai-Hsiu Lin, Jan-Gowth Chang. <b><i>RAS, BRAF,</i></b> and <b><i>TP53</i></b> Gene Mutations in Taiwanese Colorectal Cancer Patients. Onkologie 2013; 36(12): 719 doi: 10.1159/000356814
|
28 |
Wenbin Li, Tian Qiu, Wenxue Zhi, Susheng Shi, Shuangmei Zou, Yun Ling, Ling Shan, Jianming Ying, Ning Lu. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1345-3
|
29 |
Krittiya Korphaisarn, Ananya Pongpaibul, Chanin Limwongse, Ekkapong Roothumnong, Wipawi Klaisuban, Akarin Nimmannit, Artit Jinawath, Charuwan Akewanlop. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. World Journal of Gastroenterology 2015; 21(3): 926-934 doi: 10.3748/wjg.v21.i3.926
|
30 |
Carlos Gil Ferreira, Veronica Aran, Ilana Zalcberg-Renault, Ana Paula Victorino, Jonas H Salem, Martin H Bonamino, Fernando M Vieira, Mariano Zalis.
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-73
|